A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

ACCORD Collaborative Group, Tom Wilkinson, Anthony De soyza, Miles Carroll, James d. Chalmers, Michael g. Crooks, Gareth O. Griffiths, Manu Shankar-Hari, Ling-Pei Ho, Alex Horsley, Chris Kell, Beatriz Lara, Biswa Mishra, Rachel Moate, Clive P. Page, Hitesh Pandya, Jason Raw, Fred Reid, Dinesh Saralaya, Ian c. ScottSalman Siddiqui, Andy Ustianowski, Natalie Van zuydam, Ashley Woodcock, Dave Singh

Research output: Contribution to journal › Article › peer-review

21 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Nursing and Health Professions